Fluorescence-guided Surgery in Laryngeal- and Hypopharyngeal Cancer: a Feasibility Trial

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

March 1, 2027

Conditions

Squamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Hypopharynx

Interventions

DRUG

CRGD-ZW800-1

Intravenous administration of study drug at lesat 2h prior to surgery

Trial Locations (1)

Erasmus Medical Center, Rotterdam